Cerity Partners
CELG

Cerity Partners’s Celgene Corp CELG Stock Holding History

Cerity Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,631
Closed -$957K – 586
2019
Q3 		$957K Buy
9,631
+378
+4% +$35.9K 0.06% 254
2019
Q2 		$856K Sell
9,253
-10,007
-52% -$950K 0.05% 255
2019
Q1 		$1.82M Sell
19,260
-30,226
-61% -$2.64M 0.12% 175
2018
Q4 		$3.17M Sell
49,486
-26,787
-35% -$1.98M 0.21% 108
2018
Q3 		$6.83M Buy
76,273
+29,424
+63% +$2.6M 0.47% 44
2018
Q2 		$3.72M Sell
46,849
-558
-1% -$46.3K 0.27% 94
2018
Q1 		$4.23M Sell
47,407
-13,562
-22% -$1.3M 0.32% 74
2017
Q4 		$6.36M Sell
60,969
-11,776
-16% -$1.33M 0.43% 43
2017
Q3 		$10.6M Buy
+72,745
New +$9.91M 0.75% 23
2017
Q2 		– Sell
-69,504
Closed -$8.65M – 471
2017
Q1 		$8.65M Buy
69,504
+51,999
+297% +$6.22M 0.72% 19
2016
Q4 		$2.03M Buy
+17,505
New +$1.95M 2.79% 11

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Cerity Partners's CELG Position: Q4 2019 in Review

Cerity Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,631 shares — an estimated $957K sold.

Cerity Partners first reported a position in CELG in Q4 2016 and held it in 11 quarters. The position peaked at $10.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cerity Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cerity Partners sold 9,631 Celgene Corp shares in Q4 2019, an estimated $957K.
  • Cerity Partners first reported a position in Celgene Corp in Q4 2016 and held it in 11 quarters.
  • Cerity Partners's Celgene Corp position peaked at $10.6M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cerity Partners's 13F filing for Q4 2019, filed 14 Feb 2020.